Unknown

Dataset Information

Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy.


ABSTRACT: This is the first study to report changes in BMD and related risk factors among Chinese patients with HIV after initiation of tenofovir disoproxil fumarate (TDF)-containing antiretroviral therapy. Greater bone mineral density (BMD) loss was observed in patients treated with TDF, compared to those on non-TDF-containing regimens. Our findings provide important knowledge regarding the risk factors in the long-term clinical management of patients with HIV in China.

Introduction

Persons living with HIV (PLWH) are at increased risk for osteoporosis and fracture. Tenofovir disoproxil fumarate (TDF) has been associated with higher rates of bone mineral density (BMD) loss, osteoporosis, and fracture. Few studies have studied the impact among PLWH in Asia.

Methods

We analyzed retrospec

SUBMITTER: Guo F 

PROVIDER: S-EPMC9509525 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature